JERSEY
CITY, N.J., July 14,
2023 /PRNewswire/ -- WallachBeth Capital LLC, a
leading provider of capital markets and institutional execution
services, announced today that 60 Degrees Pharmaceuticals, Inc.,
(NASDAQ: SXTP; SXTPW) specialists in developing and marketing
medicines for infectious diseases has completed its previously
announced IPO of 1,415,095 units at a price of $5.30 per Unit for a total of approximately
$7.5 million of gross proceeds to the
Company. Each Unit is comprised of one share of the Company's
common stock, one tradeable warrant to purchase one share of common
stock at an exercise price of $6.095
per share, and one non-tradeable warrant to purchase one share of
the Company's common stock at an exercise price of $6.36. The shares and tradeable warrants began
trading on the Nasdaq Capital Market on July
12, 2023, under the symbols "SXTP" and "SXTPW,"
respectively.
WallachBeth Capital, LLC is the Sole Bookrunner for the
Offering.
A registration statement on Form S-1, as amended (File No.
333-269483), relating to these securities was filed with the SEC
and was declared effective on July 11,
2023. This press release shall not constitute an offer to
sell or the solicitation of an offer to buy these securities, nor
shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation, or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
About WallachBeth Capital LLC.
WallachBeth Capital offers a robust range of capital markets and
investment banking services to the healthcare community. The firm's
experience includes initial public offerings, follow-on issues,
PIPE offerings, and private transactions. The firm's website is
located at www.wallachbeth.com.
This news release does not constitute an offer to sell or a
solicitation of an offer to buy the securities described herein,
nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains forward-looking statements,
including statements regarding the anticipated use of proceeds from
the Company's offering of its units. Forward-looking statements can
be identified by words such as "believes," "expects," "estimates,"
"intends," "may," "plans," "will" and similar expressions, or the
negative of these words. Such forward-looking statements are based
on facts and conditions as they exist at the time such statements
are made and predictions as to future facts and conditions. Readers
of this press release are cautioned not to place undue reliance on
any forward-looking statements. The Company does not undertake any
obligation to update any forward-looking statement relating to
matters discussed in this press release, except as may be required
by applicable securities laws.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/wallachbeth-capital-announce-closing-of-60-degrees-pharmaceuticals-ipo-at-5-30-per-unit-301877686.html
SOURCE WallachBeth Capital LLC